Feminist language being hijacked to market medical tests Narratives around empowerment and women’s rights are being co-opted to market interventions not backed by evidence, according to new research.
Consider MHT for bones: New menopause guideline Almost a decade in the making, a toolkit refresh is the first to include advice on prescribing hormone therapy specifically for bone health.
Study linking HRT with dementia risk ‘unhelpful’ Experts point out that no causal relationship between menopausal hormone therapy and dementia has been established.
RACGP opposes GLP-1 RA prescribing restrictions Changing the authority type for initiating the diabetes medication will make it difficult for ‘already burdened’ GPs to negotiate, the PBS has been told.
Why TSH test results can lead to over-testing, over-treatment Lifestyle review is recommended as the first intervention to reduce risk of unnecessary patient harms and resource wastage.
Debate over ‘doctor-approved’ weight loss drugs obtained online Is a GP-reviewed online questionnaire clinically sufficient to safely prescribe injectable medications without a face-to-face consultation? It depends who you ask.
Menopause hormonal treatments to retain PBS listing While GPs have welcomed the news, there are concerns a subsequent price increase will represent further gaps in access to care.
‘Serious implications’ if menopause treatments removed from PBS Experts warn the proposed delisting of medications will not only impose cost-related issues, but potentially affect quality of life.
Outdated information still guides menopause management: Expert Understanding the risks and benefits of various menopausal therapies leads to better outcomes.
New breast cancer research has ‘immediate implications’ The study has produced fresh evidence about the use of androgens as a potential treatment for oestrogen receptor-positive breast cancer.